The prognostic value of the Incremental Shuttle Walk Test in Chagas cardiomyopathy

References

• Nunes MCP, Beaton A, Acquatella H, et al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation. 2018;138(12):e169–e209.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Chagas disease; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)
   Google Scholar
• Requena-Méndez A, Aldasoro E, de Lazzari E, et al. Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2015;9(2):e0003540.
   PubMed Web of Science ®Google Scholar
• Antinori S, Galimberti L, Bianco R, et al. Chagas disease in Europe: a review for the internist in the globalized world. Eur J Intern Med. 2017;43:6–15.
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Dumonteil E, Betancourt Cravioto M, et al. An unfolding tragedy of Chagas disease in North America. PLoS Negl Trop Dis. 2013;7(10):e2300.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Dones W, Morillo CA, et al. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013;62(9):767–776.
   PubMed Web of Science ®Google Scholar
• Forsyth C, Meymandi S, Moss I, et al. Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States. PLOS Negl Trop Dis. 2019;13(9):e0007447.
   PubMed Web of Science ®Google Scholar
• Rocha MO, Teixeira MM, Ribeiro AL. An update on the management of Chagas cardiomyopathy. Expert Rev Anti Infect Ther. 2007;5(4):727–743.
   PubMed Web of Science ®Google Scholar
• Montes de Oca M, Torres SH, Loyo JG, et al. Exercise performance and skeletal muscles in patients with advanced Chagas disease. Chest. 2004;125(4):1306–1314.
   PubMed Web of Science ®Google Scholar
• Baião EA, Costa Rocha MO, Lima MMO, et al. Respiratory function and functional capacity in Chagas cardiomyopathy. Int J Cardiol. 2013;168(5):5059–5061.
   PubMed Web of Science ®Google Scholar
• Vieira FC, de Melo Marinho PÉ, Brandão DC, et al. Respiratory muscle strength, the six-minute walk test and quality of life in Chagas cardiomyopathy. Physiother Res Int. 2014;19(1):8–15.
   PubMedGoogle Scholar
• Sousa GR, Costa HS, Souza AC, et al. Health-related quality of life in patients with Chagas disease: a review of the evidence. Rev Soc Bras Med Trop. 2015;48(2):121–128.
   PubMed Web of Science ®Google Scholar
• Costa HS, Lima MMO, Costa FSMd, et al. Reduced functional capacity in patients with Chagas disease: a systematic review with meta-analysis. Rev Soc Bras Med Trop. 2018;51(4):421–426.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Myers J, Abella J, et al. The added prognostic value of ventilatory efficiency to the weber classification system in patients with heart failure. Int J Cardiol. 2008;129(1):86–92.
   PubMed Web of Science ®Google Scholar
• Singh SJ, Morgan MD, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47(12):1019–1024.
   PubMed Web of Science ®Google Scholar
• Bardin MG, Dourado VZ. Association between the occurrence of falls and the performance on the Incremental Shuttle Walk Test in elderly women. Rev Bras Fisioter. 2012;16(4):275–280.
   PubMed Web of Science ®Google Scholar
• Majd S, Hewitt SM, Apps LD, et al. Understanding the measurement properties of the Incremental Shuttle Walk Test in patients with severe asthma. Respirology. 2019;24(8):752–757.
   PubMed Web of Science ®Google Scholar
• Singh S, Moiz JA, Ali MS, et al. Reliability, validity, and responsiveness of the Incremental Shuttle Walk Test in patients with interstitial lung disease. J Cardiopulm Rehabil Prev. 2018;38(6):425–429.
   PubMed Web of Science ®Google Scholar
• Ushiki A, Nozawa S, Yasuo M, et al. Associations between the distance covered in the Incremental Shuttle Walk Test and lung function and health status in patients with chronic obstructive pulmonary disease. Respir Investig. 2017;55(1):33–38.
   PubMed Web of Science ®Google Scholar
• Lelis JDa, Chaves G, Ghisi GLdM, et al. Validity of the Incremental Shuttle Walk Test to assess exercise safety when initiating cardiac rehabilitation in low-resource settings. J Cardiopulm Rehabil Prev. 2019;39(3):E1–E7.
   PubMed Web of Science ®Google Scholar
• Hanson LC, McBurney H, Taylor NF. Is the 10 m Incremental Shuttle Walk Test a useful test of exercise capacity for patients referred to cardiac rehabilitation? Eur J Cardiovasc Nurs. 2018;17(2):159–169.
   PubMed Web of Science ®Google Scholar
• Costa HS, Alves RL, Silva Sa D, et al. Assessment of functional capacity in Chagas heart disease by Incremental Shuttle Walk Test and its relation to quality-of-life. Int J Prev Med. 2014;5(2):152–158.
   PubMedGoogle Scholar
• Alves R, Lima MM, Fonseca C, et al. Peak oxygen uptake during the Incremental Shuttle Walk Test in a predominantly female population with Chagas heart disease. Eur J Phys Rehabil Med. 2016;52(1):20–27.
   PubMed Web of Science ®Google Scholar
• Costa HS, Oliveira Lima MM, Lage SM, et al. Six-minute walk test and Incremental Shuttle Walk Test in the evaluation of functional capacity in Chagas heart disease. J Exerc Rehabil. 2018;14(5):844–850.
   PubMed Web of Science ®Google Scholar
• Andrade JPd, Marin Neto JA, Paola AAVd, et al. I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy. Arq Bras Cardiol. 2011;96(6):434–442.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; American College of Chest Physicians. ATS/ACCP statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med. 2003;167(2):211–277.
   PubMed Web of Science ®Google Scholar
• Balady GJ, Arena R, Sietsema K, et al. Clinician's guide to Cardiopulmonary Exercise Testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122(2):191–225.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Arena R, Halle M, et al. 2016 Focused Update: clinical recommendations for Cardiopulmonary Exercise Testing data assessment in specific patient populations. Eur Heart J. 2018;39(14):1144–1161.
   PubMed Web of Science ®Google Scholar
• Weber KT, Kinasewitz GT, Janicki JS, et al. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation. 1982;65(6):1213–1223.
   PubMed Web of Science ®Google Scholar
• Ritt LE, Carvalho AC, Feitosa GS, et al. Cardiopulmonary exercise and 6-min walk tests as predictors of quality of life and long-term mortality among patients with heart failure due to Chagas disease. Int J Cardiol. 2013;168(4):4584–4585.
   PubMed Web of Science ®Google Scholar
• Souza AC, Magalhães LC, Teixeira-Salmela LF. Adaptação transcultural e análise das propriedades psicométricas da versão brasileira do perfil de atividade humana. Cad Saúde Pública. 2006;22(12):2623–2636.
   PubMedGoogle Scholar
• Costa HS, Lima MMO, Vieira CFD, et al. Assessment of functional performance in Chagas heart disease by Human Activity Profile Questionnaire. Disabil Rehabil. 2019;43(9):1255–1259.
   PubMed Web of Science ®Google Scholar
• Ribeiro AL, Nunes MP, Teixeira MM, et al. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol. 2012;9(10):576–589.
   PubMed Web of Science ®Google Scholar
• Morales FJ, Martinez A, Mendez M, et al. A shuttle walk test for assessment of functional capacity in chronic heart failure. Am Heart J. 1999;138(2):291–298.
   PubMed Web of Science ®Google Scholar
• Lewis ME, Newall C, Townend JN, et al. Incremental Shuttle Walk Test in the assessment of patients for heart transplantation. Heart. 2001;86(2):183–187.
   PubMed Web of Science ®Google Scholar
• Pulz C, Diniz RV, Alves AN, et al. Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure. Can J Cardiol. 2008;24(2):131–135.
   PubMed Web of Science ®Google Scholar
• Keell SD, Chambers JS, Francis DP, et al. Shuttle-walk test to assess chronic heart failure. Lancet. 1998;352(9129):705.
   PubMed Web of Science ®Google Scholar
• Poggio R, Arazi HC, Giorgi M, et al. Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: a meta-analysis of the published literature. Am Heart J. 2010;160(6):1004–1014.
   PubMed Web of Science ®Google Scholar
• Shen Y, Zhang X, Ma W, et al. VE/VCO2 slope and its prognostic value in patients with chronic heart failure. Exp Ther Med. 2015;9(4):1407–1412.
   PubMed Web of Science ®Google Scholar
• Sarullo FM, Fazio G, Brusca I, et al. Cardiopulmonary Exercise Testing in patients with chronic heart failure: prognostic comparison from peak VO2 and VE/VCO2 slope. Open Cardiovasc Med J. 2010;4(1):127–134.
   PubMedGoogle Scholar
• Tabet JY, Beauvais F, Thabut G, et al. A critical appraisal of the prognostic value of the VE/VCO2 slope in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2003;10(4):267–272.
   PubMedGoogle Scholar
• Arena R, Myers J, Aslam SS, et al. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J. 2004;147(2):354–360.
   PubMed Web of Science ®Google Scholar
• Arena R, Myers J, Guazzi M. The clinical importance of Cardiopulmonary Exercise Testing and aerobic training in patients with heart failure. Braz J Phys Ther. 2008;12:75–87.
   Web of Science ®Google Scholar
• Morales FJ, Montemayor T, Martinez A. Shuttle versus six-minute walk test in the prediction of outcome in chronic heart failure. Int J Cardiol. 2000;76(2–3):101–105.
   PubMed Web of Science ®Google Scholar